These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2977075)

  • 41. Can inhibiting dihydropyrimidine dehydrogenase limit hand-foot syndrome caused by fluoropyrimidines?
    Yen-Revollo JL; Goldberg RM; McLeod HL
    Clin Cancer Res; 2008 Jan; 14(1):8-13. PubMed ID: 18172246
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Palmar-plantar erythrodysestasia syndrome associated with 5-fluorouracil treatment.
    Comandone A; Bretti S; La Grotta G; Manzoni S; Bonardi G; Berardo R; Bumma C
    Anticancer Res; 1993; 13(5C):1781-3. PubMed ID: 8267382
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Oral mucosa and skin complications due to treatment with gold preparations].
    Bardadin T; Gutowski W; Robakowa I
    Reumatologia; 1968; 6(4):287-90. PubMed ID: 4237529
    [No Abstract]   [Full Text] [Related]  

  • 44. Lichen planus-like drug reaction associated with recombinant human growth hormone therapy in a child patient with Turner syndrome.
    Soares MQ; Mendonca EF
    Dermatol Online J; 2016 Mar; 22(3):. PubMed ID: 27136634
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Skin problems associated with pegylated liposomal doxorubicin-more than palmoplantar erythrodysesthesia syndrome.
    Mangana J; Zipser MC; Conrad C; Oberholzer PA; Cozzio A; Knuth A; French LE; Dummer R
    Eur J Dermatol; 2008; 18(5):566-70. PubMed ID: 18693162
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Erythematous eruption of the palms and soles associated with mitotane therapy.
    Zuehlke RL
    Dermatologica; 1974; 148(2):90-2. PubMed ID: 4276191
    [No Abstract]   [Full Text] [Related]  

  • 47. Hairloss and scaling with proguanil.
    Hanson SN; Kuylen K; Björkman AB
    Lancet; 1989 Jan; 1(8631):225. PubMed ID: 2563137
    [No Abstract]   [Full Text] [Related]  

  • 48. The pathogenetic mechanism of anthracycline-induced palmar-plantar erythrodysesthesia.
    Martschick A; Sehouli J; Patzelt A; Richter H; Jacobi U; Oskay-Ozcelik G; Sterry W; Lademann J
    Anticancer Res; 2009 Jun; 29(6):2307-13. PubMed ID: 19528496
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prospective study of the cutaneous adverse effects of sorafenib, a novel multikinase inhibitor.
    Autier J; Escudier B; Wechsler J; Spatz A; Robert C
    Arch Dermatol; 2008 Jul; 144(7):886-92. PubMed ID: 18645140
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fluorouracil and the palmar-plantar erythrodysesthesia syndrome.
    Atkins JN
    Ann Intern Med; 1985 Mar; 102(3):419. PubMed ID: 3155925
    [No Abstract]   [Full Text] [Related]  

  • 51. Adverse drug reactions in the mouth.
    Porter SR; Scully C
    Clin Dermatol; 2000; 18(5):525-32. PubMed ID: 11134847
    [No Abstract]   [Full Text] [Related]  

  • 52. Fixed drug eruption induced by ofloxacin.
    Kawada A; Hiruma M; Noguchi H; Banba K; Ishibashi A; Banba H; Marshall J
    Contact Dermatitis; 1996 Jun; 34(6):427. PubMed ID: 8879931
    [No Abstract]   [Full Text] [Related]  

  • 53. Predisposing risk factors for palmar-plantar erythrodysesthesia when using liposomal doxorubicin to treat recurrent ovarian cancer.
    Tanyi JL; Smith JA; Ramos L; Parker CL; Munsell MF; Wolf JK
    Gynecol Oncol; 2009 Aug; 114(2):219-24. PubMed ID: 19446868
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Chemotherapy-induced acral erythema: a clinical and histopathologic study of 44 cases].
    Hueso L; Sanmartín O; Nagore E; Botella-Estrada R; Requena C; Llombart B; Serra-Guillén C; Alfaro-Rubio A; Guillén C
    Actas Dermosifiliogr; 2008 May; 99(4):281-90. PubMed ID: 18394404
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bullous acral eruption related to secukinumab.
    Blackcloud P; Dupuy E; Kang Y; Smart C; Hsiao J
    Dermatol Online J; 2019 Jun; 25(6):. PubMed ID: 31329391
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reaction to topical fluorouracil of secondary lymphedema.
    Grattan CE; Guerrier CJ
    Arch Dermatol; 1985 Dec; 121(12):1484. PubMed ID: 2933003
    [No Abstract]   [Full Text] [Related]  

  • 57. Chemotherapy-induced palmer planter erythrodysesthesia.
    Bhasin S; Sunita ; Gupta DK; Kataria SP; Saluja S; Sharma M
    J Assoc Physicians India; 2005 Feb; 53():155-6. PubMed ID: 15847041
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histologic patterns of polyethylene glycol-liposomal doxorubicin-related cutaneous eruptions.
    Cady FM; Kneuper-Hall R; Metcalf JS
    Am J Dermatopathol; 2006 Apr; 28(2):168-72. PubMed ID: 16625083
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Skin reactions to 5-fluorouracil.
    Bernstein T
    N Engl J Med; 1977 Aug; 297(6):337-8. PubMed ID: 141618
    [No Abstract]   [Full Text] [Related]  

  • 60. Amiodarone-induced linear IgA disease.
    Primka EJ; Liranzo MO; Bergfeld WF; Dijkstra JW
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):809-11. PubMed ID: 7929933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.